Citigroup
DMAQR

Citigroup’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Citigroup’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25,000
Closed -$3.5K – 5797
2023
Q1 		$3.5K Hold
25,000
– – ﹤0.01% 5010
2022
Q4 		$1.25K Sell
25,000
-11,201
-31% -$641 ﹤0.01% 5360
2022
Q3 		$1K Hold
36,201
– – ﹤0.01% 5721
2022
Q2 		$4K Hold
36,201
– – ﹤0.01% 5733
2022
Q1 		$7K Hold
36,201
– – ﹤0.01% 5712
2021
Q4 		$12K Buy
+36,201
New +$11.4K ﹤0.01% 5534

Other funds holding DMAQR

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return